Reference (study, year) | Animal | Total N | Age | Weight(SD) | Follow-up | Timing of Treatment (post-MI) | Baseline EF or FS (post-MI) | Encapsulation materials | Hydrogel | Funding Source | Setting | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Rufaihah et al. 2013 [18] | Combined group | Rats | 7F | Not reported | 250 g | 4w | 0 | Not reported | VEGF-A | PEGylated fibrinogen hydrogel | Agency | Singapore |
Hydrogel group | 7F | |||||||||||
Rufaihah et al. 2017 [19] | Combined group | Rats | 10 M | Not reported | 250-300 g | 4w | 0 | Not reported | VEGF+ANG-1 | polyethylene glycol-fibrinogen (PF) hydrogels | Agency/Idustry | China |
Hydrogel group | 10 M | |||||||||||
Rocker et al. 2022 [20] | Combined group | Mice | 4 | Not reported | 24–28 g | 4w | 0 | Not reported | VEGF+IL-10 + PDGF | S-GC-PNIPAM hydrogel | Agency | USA |
Hydrogel group | 4 | |||||||||||
Steele et al. 2017 [21] | Combined group | Rats | 10 M | Not reported | 250–300 g | 4w | 0 | Not reported | HGFdf | PEG-PNIPAM-P1 hydrogel | Agency | USA |
Hydrogel group | 10 M | |||||||||||
Steele et al. 2020 [22] | Combined group | Rats | 12 M | Not reported | 250-300 g | 4w | 0 | Not reported | HGFdf+ESA 1α | hydhyaluronic acid poly(ethyleneglycol) poly(lactic acid) hydrogel | Agency | USA |
Hydrogel group | 12 M | |||||||||||
Steele et al. 2020 [22] | Combined group | Sheep | 7 M | Not reported | 8w | 0 | Not reported | HGFdf+ESA 1α | hydhyaluronic acid poly(ethyleneglycol) poly(lactic acid) hydrogel | Agency | USA | |
Hydrogel group | 7 M | |||||||||||
Chow et al. 2017 [23] | Combined group | Rats | 5 M | 8 weeks | 10w | 0 | EF = 45.4 ± 7.8 | Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte | PEG hydrogel | Agency/Idustry | UK | |
Hydrogel group | 6 M | |||||||||||
Gaffey et al. 2015 [24] | Combined group | Rats | 10 M | Not reported | 250-300 g | 4w | 0 | Not reported | Rat bone marrow-derived endothelial progenitor cells | hyaluronic acid hydrogel | USA | |
Hydrogel group | 10 M | |||||||||||
Hakravarti et al. 2018 [25] | Combined group | Mice | 4F | 12 weeks | 3w | 0 | Not reported | Human adipose-derived stem cells | gelatin methacrylamide (GelMA) | Agency | USA | |
Hydrogel group | 4F | |||||||||||
Paul et al. 2014 [26] | Combined group | Rats | 7 M | Not reported | 200-250 g | 2w | 0 | EF = 36.6 | Graphene oxide +VEGF | GelMA hydrogel | Agency/Idustry | USA |
Hydrogel group | 7 M | |||||||||||
Qian et al. 2022 [27] | Combined group | Rats | 8 M | Not reported | Not reported | 4w | 0w | Not reported | platelet concentrates including PRP | ALG-HA hydrogels | Agency/Idustry | China |
Hydrogel group | 8 M | |||||||||||
Xu et al. 2017 [28] | Combined group | Rats | 6 M | Not reported | 225-250 g | 4w | 1w | Not reported | rat bone-marrow mesenchymal stem cells | chitosan hydrogel | Agency | China |
Hydrogel group | 6 M | |||||||||||
Follin et al. 2018 [29] | Combined group | Rats | 13 M | Not reported | 266 ± 15 g | 4w | 0w | EF = 45.04 ± 9.08 | adipose-derived Mesenchymal stem cell | Alginate Hydrogel | Agency | Denmark |
Hydrogel group | 10 M | |||||||||||
Fu et al. 2022 [30] | Combined group | Rats | 10 M | 8 weeks | 200–250 g | 4w | 0w | bFGF | CMCS-S-S-Py and rBSA hydrogel | Agency/Idustry | China | |
Hydrogel group | 10 M | |||||||||||
Purcell et al. 2018 [31] | Combined group | Pigs | 7 M | Not reported | 20,000 g | 4w | 0w | Not reported | rTIMP-3 | hyaluronic acid (HA)-based hydrogel | Agency | USA |
Hydrogel group | 7 M | |||||||||||
Purcell et al. 2014 [32] | Combined group | Pigs | 7 M | Not reported | 25,000 g | 4w | 0w | Not reported | rTIMP-3 | Dextran sulphate (DS) / ALD modification of its diol groups hydrogels | Agency/Idustry | USA |
Hydrogel group | 7 M | |||||||||||
Cimenci et al. 2022 [33] | Combined group | Mice | 7F | Not reported | Not reported | 5w | 0w | Not reported | fisetin | thermoresponsive collagen hydrogel | Agency/Idustry | Canada |
Hydrogel group | 7F | |||||||||||
Fan et al. 2019 [34] | Combined group | Rats | 12F | Not reported | 200-220 g | 4w | 0w | Not reported | GST-TIMP-bFGF | collagen-GSH hydrogel | Agency/Idustry | China |
Hydrogel group | 12F | |||||||||||
Chen et al. 2018 [35] | Combined group | Rats | 11 M | Not reported | 350-375 g | 5w | 0w | Not reported | EPCs EVs | adamantane-modified HA (Ad-HA) and β-cyclodextrin-modified HA (CD-HA) shear-thinning hydrogel (STG) | Agency/Idustry | USA |
Hydrogel group | 10 M | |||||||||||
Kim et al. 2020 [36] | Combined group | Mice | 9 M | 7 weeks | 20-22 g | 4w | 0w | Not reported | MSC | gelatin–hydroxyphenyl propionic acid (GH) hydrogels | Agency | Korea |
Hydrogel group | 9 M | |||||||||||
Han et al. 2019 [36] | Combined group | Rats | 5 M | 4w | 0w | Not reported | UMSC exosomes | (PA-GHRPS and NapFF) PGN hydrogel | Agency/Idustry | China | ||
Hydrogel group | 5 M | |||||||||||
Chen et al. 2013 [37] | Combined group | Rats | 8 M | 6 weeks | 200-250 g | 4w | 0w | EF = 37.9 | allogeneic bone marrow mononuclear cells | hyaluronan (HA) hydrogel | Agency/Idustry | Taiwan of China |
Hydrogel group | 8 M | |||||||||||
Chen et al. 2014 [38] | Combined group | Pigs | 7 | Not reported | Not reported | 8w | 0w | EF = 45.8 | bone marrow mononuclear cells | hyaluronan (HA) hydrogel | Agency/Idustry | Taiwan of China |
Hydrogel group | 8 | |||||||||||
Projahn et al. 2014 [39] | Combined group | Mice | 8 M | Not reported | 25–26 g | 4w | 0w | Not reported | CXCL12 (S4V)、Met-CCL5 | sP(EO-stat-PO)/oxidation of thiolated (FDH) / PEG-diacrylate(SDH) | Agency/Idustry | Germany |
Hydrogel group | 8 M | |||||||||||
Mathieu et al. 2012 [40] | Combined group | Rats | 9F | Not reported | 180-190 g | 8w | 0w | Not reported | rat bone-marrow mesenchymal stem cells | Silanized-Hydroxypropyl Methyicellulose hydrogel | Agency/Idustry | France |
Hydrogel group | 7F | |||||||||||
Xu et al. 2014 [41] | Combined group | Rats | 5F | Not reported | 150-200 g | 4w | 0w | Not reported | Rat bone marrow mesenchymal stem cells | Col-SH/OAC-PEG-OAC hybrid hydrogels | Agency/Idustry | China |
Hydrogel group | 5F | |||||||||||
Chen et al. 2017 [42] | Combined group | Mice | 6 M | 8-11 weeks | 2w | 0w | Not reported | Curcumin+NO | FFE-ss-ERGD hydrogels | Agency/Idustry | China | |
Hydrogel group | 6 M | |||||||||||
Awada et al. 2017 [43] | Combined group | Rats | 8 M | 6-7 weeks | 175-225 g | 8w | 0w | Not reported | TIMP-3 + FGF-2+ SDF-1α | fibrin gel hydrogels | Agency | USA |
Hydrogel group | 8 M | |||||||||||
Wang et al. 2010 [44] | Combined group | Rats | 8F | 6 weeks | 4w | 0w | Not reported | bFGF | chitosan hydrogel | Agency/Idustry | China | |
Hydrogel group | 8F | |||||||||||
Wang et al. 2012 [45] | Combined group | Rats | 32F | 6 weeks | 4w | 1w | Not reported | mouse embryonic stem cells | OPF hydrogels [fumaryl chloride and poly(ethylene glycol) (PEG)] | Agency | USA | |
Hydrogel group | 24F | |||||||||||
Wang et al. 2014 [46] | Combined group | Rats | 20 M | Not reported | 250 ± 10 g | 4w | 0w | Not reported | CD29 Rat brown adipose-derived stem cells | chitosan hydrogel | Agency/Idustry | China |
Hydrogel group | 20 M | |||||||||||
Ding et al. 2020 [47] | Combined group | Rats | 6 M | Not reported | 250 g | 4w | 0w | EF = 42.4 FS = 21.9 | mesenchymal stem cells | methacrylate hyaluronic acid hydrogel | Agency/Idustry | China |
Hydrogel group | 6 M | |||||||||||
Li et al. 2018 [48] | Combined group | Mice | 4 M | 8–10 weeks | 20 ± 5 g | 4w | 0w | Not reported | Mouse Induced pluripotent stem (MiPS) cells | folic acid (FA) Hydrogel | Agency/Idustry | China |
Hydrogel group | 4 M | |||||||||||
Zhu et al. 2017 [49] | Combined group | Rats | 7 M | 8-10 weeks | 200-250 g | 4w | 0w | Not reported | bFGF | Dex-PCL-HEMA/PNIPAAm hydrogel | Agency/Idustry | China |
Hydrogel group | 7 M | |||||||||||
Cohen et al. 2014 [50] | Combined group | Mice | 5 M | 10 weeks | 25-30 g | 2w | 0w | Not reported | Neuregulin-1β | hyaluronate hydrogel | Agency | USA |
Hydrogel group | 5 M | |||||||||||
Cohen et al. 2020 [22] | Combined group | Sheep | 6 M | 26-30 weeks | 35,000-40,000 g | 8w | 0w | Not reported | Neuregulin-1β | hyaluronate hydrogel | Agency | USA |
Hydrogel group | 4 M | |||||||||||
Ding et al. 2020 [51] | Combined group | Rats | 5 M | 8 weeks | 200-250 g | 4w | 0w | Not reported | catalase + hyperbranched polymers | Reactive Oxygen Species Scavenging and O2 Generating Injectable Hydrogel/hyaluronic acid (HA-MA) | Agency/Idustry | China |
Hydrogel group | 5 M | |||||||||||
Zhou et al. 2021 [52] | Combined group | Rats | 10 M | Not reported | 250 ± 10 g | 4w | 0w | Not reported | melanin | Alginate (Alg) hydrogels | Agency/Idustry | China |
Hydrogel group | 10 M | |||||||||||
Chen et al. 2021 [53] | Combined group | Rats | 4 M | 6-8 weeks | 220-250 g | 4w | 0w | Not reported | Astragaloside IV | (PEGDA-PBA) - (HA-SH) hydrogel | Agency/Idustry | China |
Hydrogel group | 4 M | |||||||||||
Chen et al. 2014 [54] | Combined group | Rabbits | 7 M | Not reported | 2200-2600 g | 4w | 1w | EF = 56.13 ± 7.51 | Rabbit bone marrow stem cells | α-cylcodextrin/MPEG–PCL–MPEG hydrogel | Idustry | China |
Hydrogel group | 7 M | |||||||||||
Wu et al. 2011 [55] | Combined group | Rats | 10 | Not reported | 200-250 g | 5w | 1w | FS = 28.9 | VEGF | PVL-b-PEG-b-PVL/aliphatic polyester hydrogel (HG) | Agency/Idustry | Canada |
Hydrogel group | 11 | |||||||||||
Khan et al. 2022 [56] | Combined group | Rats | 9F | Not reported | 250-300 g | 4w | 0w | Not reported | hAMSC/amniotic stromal mesenchymal stem cells | chitosan and hyaluronic acid (C/HA) based hydrogel | Agency | Canada |
Hydrogel group | 10F | |||||||||||
Cheng et al. 2012 [57] | Combined group | Mice | 8 M | 10-12 weeks | Not reported | 3w | 0w | EF = 31.8 | Cardiosphere-derived cells (CDCs) | hyaluronan and porcine gelatin hydrogel | Agency | USA |
Hydrogel group | 8 M | |||||||||||
Zhu et al. 2022 [58] | Combined group | Rats | 6 M | Not reported | 200 g | 4w | 0w | Not reported | Mesenchymal stem cell and 68Ga3+ cations | GNR@SNs/PLGA-PEG-PLGA hydrogel | Agency/Idustry | China |
Hydrogel group | 6 M | |||||||||||
Wu et al. 2023 [59] | Combined group | Mice | 6 M | 8 weeks | 22-25 g | 4w | 0w | EF = 37.55 FS = 19 | SDF-1/CMs | dECM hydrogel | Agency/Idustry | China |
Hydrogel group | 6 M | |||||||||||
Montazeri et al. 2020 [60] | Combined group | Rats | 5 M | 8 weeks | 250–300 g | 4w | 0w | Not reported | vascular endothelial growth factor (VEGF)/ hESC-CPC-derived cardiomyocytes | fibrin hydrogel | Agency/Idustry | Iran |
Hydrogel group | 5 M | |||||||||||
Reis et al. 2015 [61] | Combined group | Rats | 7 M | Not reported | 200–250 g | 6w | 0w | Not reported | prosurvival angiopoietin-1–derived peptide, QHREDGS | chitosan-collagen hydrogel | Agency/Idustry | Canada |
Hydrogel group | 7 M | |||||||||||
Liu et al. 2020 [62] | Combined group | Mice | 8 | Not reported | Not reported | 4w | 0w | Not reported | bone marrow-derived Mesenchymal stem cell | chitosan (CS) thermosensitive hydrogel | Agency/Idustry | China |
Hydrogel group | 8 | |||||||||||
Vong et al. 2018 [63] | Combined group | Mice | 6 M | 7-8 weeks | 32–35 g | 4w | 0w | Not reported | NO | PMNT-PEG-PMNT PArg-PEG-PArg+PAAc | Agency/Idustry | Japan |
Hydrogel group | 6 M | |||||||||||
Gao et al. 2020 [64] | Combined group | Mice | 5 M | 8-10 weeks | Not reported | 4w | 0w | Not reported | Mesenchymal stem cells | bioglass (BG)/γ-polyglutamic acid/chitosan hydrogel | Agency/Idustry | China |
Hydrogel group | 5 M | |||||||||||
Ciuffreda et al. 2018 [65] | Combined group | Rats | 10F | Not reported | Not reported | 4w | 1w | EF25.14 ± 4.15 FS30.90 ± 4.68 | rat bone-marrow MSC | polyethylene glycol (PEG)-based hydrogel containing heparin (H-HG) | Agency | Italy |
Hydrogel group | 10F | |||||||||||
Chang et al. 2016 [66] | Combined group | Pigs | 6 M | 20 weeks | 22.26 ± 0.78 kg | 8w | 0w | EF = 47.5 | human cord blood mononuclear cells | hyaluronan (HA) hydrogel | Agency/Idustry | Taiwan of China |
Hydrogel group | 6 M | |||||||||||
Chen et al. 2019 [67] | Combined group | Rats | 10 M | Not reported | Not reported | 4w | 0w | Not reported | IL-10 | AdHA and CDHA hydrogel | Agency/Idustry | USA |
Hydrogel group | 8 M | |||||||||||
Song et al. 2014 [68] | Combined group | Rats | 10 M | 6 weeks | Not reported | 4w | 0w | Not reported | stem cell homing factor (SDF-1) angiogenic peptides | Biomimetic hyaluronic acid based hydrogel | Agency | Korea |
Hydrogel group | 10 M | |||||||||||
Qi et al. 2020 [69] | Combined group | Rats | 8 M | Not reported | 200-250 g | 4w | 1w | Not reported | Bioglass | Alginate hydrogel | Agency/Idustry | China |
Hydrogel group | 8 M | |||||||||||
Bao et al. 2017 [70] | Combined group | Rats | 13 M | Not reported | 250 ± 20 g | 4w | 0w | Not reported | adipose tissue-derived stromal cells | PEG-MEL/HA-SH/GO hydrogels | Agency/Idustry | China |
Hydrogel group | 13 M | |||||||||||
Firoozi et al. 2020 [71] | Combined group | Rats | 6 M | Not reported | 280-350 g | 4w | 0w | Not reported | human bone marrow-derived mesenchymal stem cells | (RADA)4-SDKP hydrogel | Agency/Idustry | Iran |
Hydrogel group | 6 M | |||||||||||
Shafei et al. 2022 [72] | Combined group | Rats | 6 M | 12 weeks | 250-280 g | 4w | 0w | FS = 30 | microRNA-126/146a mimics in exosomes | alginate hydrogel | Agency | USA |
Hydrogel group | 6 M | |||||||||||
Lü et al. 2010 [73] | Combined group | Rats | 10 M | 6 weeks | Not reported | 4w | 1w | Not reported | nuclear-transferred embryonic stem cells | temperature-responsive chitosan hydrogel | Agency/Idustry | China |
Hydrogel group | 10 M | |||||||||||
Zhu et al. 2022 [58] | Combined group | Rats | 10 M | 6 weeks | Not reported | 4w | 0w | Not reported | Umbilical cord mesenchymal stem cells | GelMA-O5/rGO hydrogels | Agency/Idustry | China |
Hydrogel group | 10 M | |||||||||||
Bao et al. 2023 [74] | Combined group | Rats | 5 M | Not reported | 200-220 g | 4w | 1w | Not reported | superparamagnetic iron oxide (SPIO) | chitosan/β-glycerophosphate (CS/GP) hydrogel | Agency/Idustry | China |
Hydrogel group | 5 M | |||||||||||
Wang et al. 2009 [75] | Combined group | Rats | 12 M | Not reported | 200–250 g | 4w | 0w | Not reported | recombined human erythropoietin | α-cyclodextrin/MPEG–PCL–MPEG hydrogel | Agency | China |
Hydrogel group | 12 M | |||||||||||
Wang et al. 2009 [76] | Combined group | Rabbits | 8 M | Not reported | 2200–2600 g | 4w | 0w | Not reported | Bone marrow stem cells | α-cyclodextrin/MPEG–PCL–MPEG hydrogel | Agency/Idustry | China |
Hydrogel group | 8 M | |||||||||||
Vu et al. 2015 [77] | Combined group | Pigs | 6 M | Not reported | 65,000-70,000 g | 8w | 0w | Not reported | PRP, allopurinol, ascorbic acid and ibuprofen | Gelatin hydrogel | Agency | Singapore |
Hydrogel group | 6 M | |||||||||||
Kraehenbuehl et al. 2011 [78] | Combined group | Rats | 8 M | Not reported | 200-250 g | 6w | 0w | EF = 52.7 | hESC-derived ELC + SMLC+Tβ4 | PEG-hydrogels | Agency/Idustry | USA |
Hydrogel group | 8 M | |||||||||||
Wan et al. 2014 [79] | Combined group | Rats | 14 M | Not reported | 200-250 g | 4w | 0w | Not reported | short-hairpin RNA of angiotensin | (Dex-PCL-HEMA/PNIPAAm) hydrogel | Agency/Idustry | China |
Hydrogel group | 14 M | |||||||||||
Wang et al. 2018 [80] | Combined group | Rats | 17 M | Not reported | 250 ± 20 g | 6w | 0w | Not reported | plasmid DNA-eNOs + ADSCs | TA-PEG/HA-SH hydrogels | Agency/Idustry | China |
Hydrogel group | 16 M | |||||||||||
Lu et al. 2009 [81] | Combined group | Rats | 12F | Not reported | Not reported | 4w | 1w | Not reported | Mouse embryonic stem cells | temperature-responsive chitosan hydrogel | Agency/Idustry | China |
Hydrogel group | 13F | |||||||||||
Li et al. 2014 [82] | Combined group | Rats | 6 M | Not reported | 250 ± 20 g | 4w | 0w | Not reported | Rat brown adipose-derived stem cells | SWCNTs-modified PNIPAAm hydrogel | Agency/Idustry | China |
Hydrogel group | 6 M | |||||||||||
Li et al. 2010 [83] | Combined group | Rabbits | 11 M | Not reported | 2000–2500 g | 4w | 1w | Not reported | bone marrow-derived mononuclear cells | Dex-PCL-HEMA/PNIPAAm hydrogel | Agency/Idustry | China |
Hydrogel group | 8 M | |||||||||||
Hu et al. 2022 [84] | Combined group | Mice | 5 M | 8-10 weeks | 4w | 0w | Not reported | ISL1-Mesenchymal stem cell-Exo | angiogenin-1 hydrogel (Ang-1 gel) | Agency/Idustry | China | |
Hydrogel group | 5 M | |||||||||||
Li et al. 2021 [85] | Combined group | Pigs | 6 M | Not reported | 45,000-50,000 g | 4w | 0w | EF = 35 | MSN / miR-21-5p | gelatin hydrogels | Agency/Idustry | China |
Hydrogel group | 6 M | |||||||||||
Liu et al. 2021 [86] | Combined group | Rats | 20 M | 6-8 weeks | 200 ± 10 g | 4w | 0w | Not reported | puerarin + rBMesenchymal stem cell | hyaluronic acid (HA-Tyr) hydrogel | Agency/Idustry | China |
Hydrogel group | 20 M | |||||||||||
Wu et al. 2021 [87] | Combined group | Mice | 15 M | 8 weeks | 22-25 g | 4w | 0w | Not reported | VEGF and B/SF microspheres | alginate based composite hydrogel | Agency/Idustry | China |
Hydrogel group | 15 M | |||||||||||
Chen et al. 2020 [88] | Combined group | Mice | 20 M | 8-12 weeks | 4w | 0w | EF = 36.4 | Rat adipose-derived mesenchymal stem cells | Col-Transglutaminase cross-linked gelatin | Agency/Idustry | China | |
Hydrogel group | 20 M | |||||||||||
Zhang et al. 2021 [89] | Combined group | Mice | 5 M | 22-28 g | 4w | 0w | Not reported | Dendritic cell-derived exosomes (DEXs) | Alginate hydrogel | Agency/Idustry | China | |
Hydrogel group | 5 M | |||||||||||
Chen et al. 2020 [90] | Combined group | Mice | 13 M | 6 weeks | 4w | 0w | Not reported | colchicine | (PLGA–PEG–PLGA) hydrogel | Agency/Idustry | China | |
Hydrogel group | 11 M | |||||||||||
Xia et al. 2015 [91] | Combined group | Mice | 8F | Not reported | Not reported | 4w | 0w | Not reported | Mouse bone marrow mesenchymal stem cells | poly(NIPAAm-co-HEMA-co-HEMAPCL)-type I collagen hydrogel | Agency | China |
Hydrogel group | 8F | |||||||||||
Lyu et al. 2020 | ||||||||||||
Combined group | Rats | 5 M | Not reported | 220 ± 20 g | 4w | 0w | Not reported | MSC aggregates (FMAs) hMesenchymal stem cell+PLGA | OHA@HHA hydrogel | Agency/Idustry | China | |
Hydrogel group | 5 M | |||||||||||
Sakakibara et al. 2002 [92] | Combined group | Rats | 10 M | Not reported | 250-290 g | 4w | 1w | FS = 19.8 ± 4.1 | bFGF+ fetal cardiomyocyte | gelatin hydrogels | Agency | Japan |
Hydrogel group | ||||||||||||
Zheng et al. 2022 [93] | Combined group | Rats | 3 M | Not reported | 250 ± 20 g | 4w | 0w | Not reported | bone mesenchymal stem cells (BMesenchymal stem cell)/KLT (a VEGF mimetic peptide with pro-angiogenic effects) | MaHA/B-G-SH/Fe3+ hydrogels | Agency/Idustry | China |
Hydrogel group | 3 M | |||||||||||
Zheng et al. 2022 [94] | Combined group | Rats | 3 M | Not reported | 250 ± 20 g | 4w | 0w | Not reported | S1P SS-31(plasma enzyme-degradable peptide)/Lipo | PAMB-G-TK/4-Arm-PEG-SG Hydrogels | Agency/Idustry | China |
Hydrogel group | 3 M | |||||||||||
Liu et al. 2012 [95] | Combined group | Rats | 22 M | Not reported | Not reported | 4w | 0w | Not reported | Rat adipose-derived mesenchymal stem cells | chitosan hydrogel | Agency/Idustry | China |
Hydrogel group | ||||||||||||
Yuan et al. 2019 [96] | Combined group | Rats | 8 M | 9–10 weeks | 200 ± 20 g | 4w | 0w | Not reported | Mydgf | citrate-containing polyester hydrogel (PPC-ET/PEG Hydrogels) | Agency/Idustry | China |
Hydrogel group |